PharmaShots | Incisive News in 3 Shots

Subscribe Now

Label Update

Novartis' Beovu (brolucizumab) Receives EMA's Approval for its Safety Label Update to Treat Wet Age-Related Macular Degeneration

Novartis' Beovu (brolucizumab) Receives EMA's Approval for its Safety Label Update to Treat Wet Age-Related Macular Degeneration

September 15, 2020

Eli Lilly's Trulicity (dulaglutide) Receives CHMP Recommendation for Label Update to Include Results from REWIND Study

Eli Lilly's Trulicity (dulaglutide) Receives CHMP Recommendation for Label Update to Include Results from REWIND Study

September 20, 2019

Novartis Receives EU Approval for Cosentyx's (secukinumab) Label Update in Patients with Psoriatic Arthritis (PsA)

Novartis Receives EU Approval for Cosentyx's (secukinumab) Label Update in Patients with Psoriatic Arthritis (PsA)

October 26, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us